Author

R. D. Cardin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. S. Anderson· 2 shared D. K. Rai· 2 shared K. M. White· 2 shared A. Garcia-Sastre· 1 shared A. Gribenko· 1 shared B. A. Stanfield· 1 shared B. Kreiswirth· 1 shared B. L. McGovern· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. S. Anderson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Development of a mouse salivary gland-derived mesenchymal cell line for immunological studies of murine cytomegalovirus

T. M. White, B. A. Stanfield, C. M. Bonavita, J. S. Rudd, R. D. Cardin

This paper develops a BALB/c-derived mouse salivary gland mesenchymal cell line for improved MCMV immunological studies.

bioRxiv · Mar 3, 2022 · PreprintMicrobiology

Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant

R. Rosales, B. L. McGovern, M. L. Rodriquez, D. K. Rai, R. D. Cardin, A. S. Anderson, E. M. Sordillo, H. van Bakel, V. Simon, A. Garcia-Sastre, K. M. White

This study evaluates the antiviral activity of nirmatrelvir, molnupiravir, and remdesivir against the SARS-CoV-2 Omicron variant and confirms their potency.

bioRxiv · Jan 17, 2022 · PreprintMicrobiology

Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

D. K. Rai, I. Yurgelonis, P. McMonagle, H. A. Rothan, L. Hao, A. Gribenko, E. Titova, B. Kreiswirth, K. M. White, Y. Zhu, A. S. Anderson, R. D. Cardin

This paper evaluates the antiviral activity of Nirmatrelvir against multiple SARS-CoV-2 variants using qRT-PCR in VeroE6 cells, showing potent inhibition across all tested variants.

bioRxiv · Jan 17, 2022Microbiology